Endocrinologie et syndrome métabolique | 2

Article de révision

Neuroinflammation and Neurodegenerative Disorders of the Retina

Yoko Ozawa, Mamoru Kamoshita, Toshio Narimatsu, Norimitsu Ban, Eriko Toda, Tomohiro Okamoto, Kenya Yuki, Seiji Miyake and Kazuo Tsubota

Partagez cet article

article de recherche

An 1 h-OGLT is an Appropriate Approach for the Determination of Glucose and Insulin Dynamics in Female Functional Androgenization (Including “Polycystic Ovary Syndrome”)

Wetzka B, Textor W and Geisthovel F

Partagez cet article

Article de révision

Pharmacological Options in Cushing's Syndrome

Duran-Perez Edgar Gerardo, Moreno-Loza Oscar Tarcicio, Segovia-Palomo Antonio, Chavira-Lopez Ismael Javier, Carrasco-Tobon German and Lujano Nicolas Leslye Asela

Partagez cet article

Commentaire

Could Glucagon be a Therapeutic Option in the Management of Acute Aluminium Phosphide Toxicity?

Mohammad Arefi and Narges Tabrizchi

Partagez cet article

Endocrinologie et syndrome métabolique
Libre accès

Volume 2, Problème 1 (2013)

Neuroinflammation and Neurodegenerative Disorders of the Retina

An 1 h-OGLT is an Appropriate Approach for the Determination of Glucose and Insulin Dynamics in Female Functional Androgenization (Including “Polycystic Ovary Syndrome”)

Pharmacological Options in Cushing's Syndrome

Could Glucagon be a Therapeutic Option in the Management of Acute Aluminium Phosphide Toxicity?

Endocrinologie et syndrome métaboliqueLibre accès

Volume 2, Problème 1 (2013)

Neuroinflammation and Neurodegenerative Disorders of the Retina

An 1 h-OGLT is an Appropriate Approach for the Determination of Glucose and Insulin Dynamics in Female Functional Androgenization (Including “Polycystic Ovary Syndrome”)

Pharmacological Options in Cushing's Syndrome

Could Glucagon be a Therapeutic Option in the Management of Acute Aluminium Phosphide Toxicity?

Endocrinologie et syndrome métabolique
Libre accès

An 1 h-OGLT is an Appropriate Approach for the Determination of Glucose and Insulin Dynamics in Female Functional Androgenization (Including “Polycystic Ovary Syndrome”)